Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipentidone vs risperidone in schizophrenia (Phase II)
CTR20140090Phase 2Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ipentidone in schizophrenia, sponsored by CSPC Pharmaceutical Group. Started May 2014; status: completed.
02
Drugs
ipentidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20140090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140090.